XML 25 R71.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Note 14 - Segment Information (Details) - Operating Segment Information (USD $) In Thousands, unless otherwise specified | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2015 | Dec. 31, 2014 | Sep. 30, 2014 | Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2015 | Mar. 31, 2014 | Mar. 31, 2013
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues | $ 18,560 us-gaap_SalesRevenueNet | $ 17,830 us-gaap_SalesRevenueNet | $ 18,540 us-gaap_SalesRevenueNet | $ 16,400 us-gaap_SalesRevenueNet | $ 15,714 us-gaap_SalesRevenueNet | $ 13,116 us-gaap_SalesRevenueNet | $ 12,676 us-gaap_SalesRevenueNet | $ 11,218 us-gaap_SalesRevenueNet | $ 12,808 us-gaap_SalesRevenueNet | $ 11,361 us-gaap_SalesRevenueNet | $ 11,706 us-gaap_SalesRevenueNet | $ 10,560 us-gaap_SalesRevenueNet | $ 71,330 us-gaap_SalesRevenueNet |  | $ 52,724 us-gaap_SalesRevenueNet |  | $ 46,435 us-gaap_SalesRevenueNet |
Gross profit | 11,512 us-gaap_GrossProfit | 11,052 us-gaap_GrossProfit | 11,123 us-gaap_GrossProfit | 9,705 us-gaap_GrossProfit | 9,585 us-gaap_GrossProfit | 7,706 us-gaap_GrossProfit | 7,600 us-gaap_GrossProfit | 6,797 us-gaap_GrossProfit | 8,211 us-gaap_GrossProfit | 6,947 us-gaap_GrossProfit | 7,248 us-gaap_GrossProfit | 6,456 us-gaap_GrossProfit | 43,392 us-gaap_GrossProfit |  | 31,688 us-gaap_GrossProfit |  | 28,862 us-gaap_GrossProfit |
Selling expenses |  |  |  |  |  |  |  |  |  |  |  |  | 7,176 us-gaap_SellingExpense |  | 6,119 us-gaap_SellingExpense |  | 4,630 us-gaap_SellingExpense |
Gross profit after deducting selling expense and impairment of intangible asset |  |  |  |  |  |  |  |  |  |  |  |  | 36,216 mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset |  | 25,569 mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset |  | 24,232 mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset |
Reconciling items |  |  |  |  |  |  |  |  |  |  |  |  | (20,869)mlab_GeneralAndAdministrativeResearchAndDevelopmentOtherExpense | [1] | (12,466)mlab_GeneralAndAdministrativeResearchAndDevelopmentOtherExpense | [1] | (11,254)mlab_GeneralAndAdministrativeResearchAndDevelopmentOtherExpense | [1]
Earnings before income taxes |  |  |  |  |  |  |  |  |  |  |  |  | 15,347 us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |  | 13,103 us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |  | 12,978 us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
Biological Indicators [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  |  |  |  | 27,390 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = mlab_BiologicalIndicatorsMember |  | 22,992 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = mlab_BiologicalIndicatorsMember |  | 21,464 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = mlab_BiologicalIndicatorsMember |
Gross profit |  |  |  |  |  |  |  |  |  |  |  |  | 17,142 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = mlab_BiologicalIndicatorsMember |  | 13,187 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = mlab_BiologicalIndicatorsMember |  | 12,365 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = mlab_BiologicalIndicatorsMember |
Selling expenses |  |  |  |  |  |  |  |  |  |  |  |  | 1,551 us-gaap_SellingExpense / us-gaap_StatementBusinessSegmentsAxis = mlab_BiologicalIndicatorsMember |  | 1,350 us-gaap_SellingExpense / us-gaap_StatementBusinessSegmentsAxis = mlab_BiologicalIndicatorsMember |  | 1,552 us-gaap_SellingExpense / us-gaap_StatementBusinessSegmentsAxis = mlab_BiologicalIndicatorsMember |
Gross profit after deducting selling expense and impairment of intangible asset |  |  |  |  |  |  |  |  |  |  |  |  | 15,591 mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset / us-gaap_StatementBusinessSegmentsAxis = mlab_BiologicalIndicatorsMember |  | 11,837 mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset / us-gaap_StatementBusinessSegmentsAxis = mlab_BiologicalIndicatorsMember |  | 10,813 mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset / us-gaap_StatementBusinessSegmentsAxis = mlab_BiologicalIndicatorsMember |
Instruments [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  |  |  |  | 33,054 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = mlab_InstrumentsMember |  | 26,389 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = mlab_InstrumentsMember |  | 24,971 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = mlab_InstrumentsMember |
Gross profit |  |  |  |  |  |  |  |  |  |  |  |  | 20,763 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = mlab_InstrumentsMember |  | 16,904 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = mlab_InstrumentsMember |  | 16,497 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = mlab_InstrumentsMember |
Selling expenses |  |  |  |  |  |  |  |  |  |  |  |  | 3,441 us-gaap_SellingExpense / us-gaap_StatementBusinessSegmentsAxis = mlab_InstrumentsMember |  | 3,954 us-gaap_SellingExpense / us-gaap_StatementBusinessSegmentsAxis = mlab_InstrumentsMember |  | 3,078 us-gaap_SellingExpense / us-gaap_StatementBusinessSegmentsAxis = mlab_InstrumentsMember |
Gross profit after deducting selling expense and impairment of intangible asset |  |  |  |  |  |  |  |  |  |  |  |  | 17,322 mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset / us-gaap_StatementBusinessSegmentsAxis = mlab_InstrumentsMember |  | 12,950 mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset / us-gaap_StatementBusinessSegmentsAxis = mlab_InstrumentsMember |  | 13,419 mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset / us-gaap_StatementBusinessSegmentsAxis = mlab_InstrumentsMember |
Continuous Monitoring [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  |  |  |  | 10,886 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = mlab_ContinuousMonitoringMember |  | 3,343 us-gaap_SalesRevenueNet / us-gaap_StatementBusinessSegmentsAxis = mlab_ContinuousMonitoringMember |  |  |
Gross profit |  |  |  |  |  |  |  |  |  |  |  |  | 5,487 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = mlab_ContinuousMonitoringMember |  | 1,597 us-gaap_GrossProfit / us-gaap_StatementBusinessSegmentsAxis = mlab_ContinuousMonitoringMember |  |  |
Selling expenses |  |  |  |  |  |  |  |  |  |  |  |  | 2,184 us-gaap_SellingExpense / us-gaap_StatementBusinessSegmentsAxis = mlab_ContinuousMonitoringMember |  | 815 us-gaap_SellingExpense / us-gaap_StatementBusinessSegmentsAxis = mlab_ContinuousMonitoringMember |  |  |
Gross profit after deducting selling expense and impairment of intangible asset |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,303 mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset / us-gaap_StatementBusinessSegmentsAxis = mlab_ContinuousMonitoringMember |  | $ 782 mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset / us-gaap_StatementBusinessSegmentsAxis = mlab_ContinuousMonitoringMember |  |  |
[1] | Reconciling items include general and administrative, research and development, and other expenses.

X
- Definition General and administrative, research and development, and other expenses which comprise the reconciling items of reportable segment earnings before tax to the entity's consolidated earnings before tax. + References No definition available. + Details
Name: | mlab_GeneralAndAdministrativeResearchAndDevelopmentOtherExpense
Namespace Prefix: | mlab_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the amount of gross profit after deducting selling expenses and impairment of intangible asset for the period. + References No definition available. + Details
Name: | mlab_GrossProfitAfterDeductingSellingExpenseAndImpairmentOfIntangibleAsset
Namespace Prefix: | mlab_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_GrossProfit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(1)(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_SalesRevenueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expenses recognized in the period that are directly related to the selling and distribution of products or services. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_SellingExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=mlab_BiologicalIndicatorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=mlab_ContinuousMonitoringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=mlab_InstrumentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |